Abstract: Novel original robust gain-scheduled controller design for individualized type 1 diabetes mellitus (T1DM) subject model is presented in this paper. For controller design an LPV model is created from insulin-glucose subsystem based on Bergman's minimal model with subcutaneous insulin absorption and absorption of digested carbohydrates. Identification was performed on pharmacokinetics and pharmacodynamics characteristics of administered insulin and data collected from continuous glucose monitoring (CGM) system. The controller design approach guarantees the closed-loop stability and cost for all scheduled parameter changes. Simulation results show the benefits of the proposed approach.
INTRODUCTION
Computer modeling of type 1 diabetes mellitus (T1DM) has attracted considerable attention in the past decade. Patients with T1DM suffer from high levels of glucose concentration due to defective insulin secretion. The lack of insulin is preventing glucose uptake and utilisation by cells. Long-term high glucose concentration results in several health complications. The most common intensified insulin therapy nowadays is based on manual exogenous insulin dosing to either keep the level of basal insulin or to suppress glycemic excursions after a meal. The patient needs to take several fingerstick blood glucose measurements a day and make decisions on insulin doses. A closedloop blood glucose control would dramatically improve the life of T1DM subjects. Despite the fast development of insulin pumps and continuous glucose measurement systems, a fully autonomous control of glycemia has not been introduced in a commercially available device yet.
The robust control theory is well established for linear systems but almost all real processes are more or less nonlinear. If the plant operating region is small, one can use the robust control approaches to design a linear robust controller where the nonlinearities are treated as model uncertainties. However, for real nonlinear processes, where the operating region is large, the above mentioned controller synthesis is inapplicable. For this reason the The work has been supported by the Slovak Scientific Grant Agency VEGA, Grant No. 1/1241/12 and Grant No. 1/2256/12. The paper is one of the outcomes of the research work for the project entitled "Research center for severe diseases and related complications", "ITMS: 26240120038". "This project is being cofinanced by the European Union. We support research activities in Slovakia".
controller design for nonlinear systems is nowadays a very determinative and important field of research.
Gain-scheduling is one of the most common used controller design approaches for nonlinear systems and has a wide range of use in industrial applications. Many of the early articles were associated with flight control (Adams et al., 1992) and aerospace (Hyde and Glover, 1993) . Then, gradually, this approach has been used almost everywhere in control engineering, which was greatly helped with the introduction of LPV systems. Linear parameter-varying systems are time-varying plants whose state space matrices are fixed functions of some vector of varying parameters θ(t). They were introduced first by Jeff S. Shamma in 1988 to model gain-scheduling. Today the LPV (Linear Parameter-Varying) paradigm has become a standard formalism in systems and controls with lot of researches and articles devoted to analysis, controller design and system identification of these models (Shamma, 2012) .
The main motivation of our paper were our previous results in gain-scheduling (Veselý and Ilka, 2013) , (Ilka and Veselý, 2014a) , and the results from T1DM research (Tárník et al., 2013) , (Tárník et al., 2014) and (Ottinger et al., 2015) . In this paper a novel robust discrete gain-scheduling controller design for Bergman's minimal model of glucose-insulin dynamics coupled with insulin and carbohydrates absorption subsystems is proposed.
Our notations are standard, D ∈ R m×n denotes the set of real m×n matrices. I m is an m×m identity matrix and Z m denotes a zero matrix. If the size can be determined from the context, we will omit the subscript. P > 0 (P ≥ 0) is a real symmetric, positive definite (semidefinite) matrix.
Proceedings of the 8th IFAC Symposium on Robust Control Design, Bratislava, Slovak Republic, July 8-11, 2015 Copyright © 2015 IFACOrganisation of the paper is following. Section 2 includes problem formulation and some preliminaries are given. In Section 3 sufficient stability conditions in the form of BMI and/or LMI are given for the design of a robust discrete gain-scheduled controller. In Section 4 the obtained results are illustrated on the T1DM model.
PROBLEM FORMULATION AND PRELIMINARIES
In this section we briefly describe the mathematical model of a T1DM subject, which was based on Bergman's minimal model of insulin-glucose interaction (Bergman et al., 1979) . Later in this work the model will be used as a base for controller design and as a patient simulator for verification of the controller.
Our aim was to adjust the parameters of the proposed model so that the output of the model fits the continuous glucose monitoring (CGM) data of a particular T1DM subject. For identification of specific model parameters we used pharmacokinetics (PK) and pharmacodynamics (PD) measurements (as published in (Novo-Nordisk, 2002; Mudaliar et al., 1999) ) of the particular insulin prescribed to the patient. The information about ingested carbohydrates was also recorded during data acquisition.
T1DM model
Bergman's minimal model consists of two differential equations in the forṁ
where 
Inputs of the model (1) are plasma insulin concentration I(t) [µU/ml] and glucose rate of appearance Ra(t) [mg/kg/min]. Signal Ra(t) can have in general two sources -the absorption of glucose from gastro-intestinal tract (modeled as a subsystem) and direct intravenous glucose administration.
Insulin absorption is modeled as a separate subsystem where the output is insulin concentration I(t) (Herrero et al., 2013; Hovorka et al., 2004) . The subsystem has the formṠ Third subsystem describes the glucose absorption from gastrointestinal tract, i.e. output of the subsystem is the signal Ra(t) [mg/kg/min]. The subsystem is described as followsḊ 
Identification of model parameters
For identification of model parameters we used data collected from a male T1DM subject aged 14, with BW = 64.6 [kg] and using fast-acting insulin NovoRapid (insulin Aspart) from an insulin pump.
Insulin absorption subsystem:
The first step in model identification was identifying of insulin absorption subsystem based on pharmacokinetics data of the used insulin. PK data from (Mudaliar et al., 1999) were used. An average basal insulin infusion rate v b [µU/kg/min] of the subject during the day is known since data from insulin pump are available. Signal v(t) is a sum of bolus part v B (t) and basal part v b .
The aim is to identify the vector of unknown parameters Θ 1 = [T I k I V I ] so that the error between simulated insulin concentration I(t) and PK data is minimized. In basal (steady) state for a given v b we get the basal insulin concentration I b as the output and I(t) response after a bolus administration. We used the nonlinear least-squares optimization to identify the vector Θ 1 .
Insulin sensitivity index and insulin action time: In the next step we identified the parameter related to insulin sensitivity S I and insulin action time p 2 . These parameters determine dynamics of remote insulin signal X(t).
The measuring principle of pharmacodynamics is to maintain glycemia at basal concentration after bolus administration by intravenous glucose infusion. This glucose infusion corresponds to the signal Ra(t) in the equation (1b).
If the equation (1b) is written in the forṁ and we measure the PK, i.e.Ġ(t) = 0, then
It is obvious that parameter S G has minor influence in order to achieveĠ(t) = 0, so we assume S G = 0 during this step of parameter identification.
The aim is to identify vector of unknown parameters Θ 2 = [S I p 2 ] so that the error between G(t) and G b is minimized. Signal Ra(t) is given by PD data.
Finalizing the model: At last, remaining parameters S G and T D are identified based on CGM data. The data containing both basal and bolus insulin dosing together with the amount of ingested carbohydrates were used as inputs to the model. Now we are identifying a vector of unknown parameters
so that the error between measured CGM data and the simulator output is minimized. Again, nonlinear least-square optimization was used.
All identified parameters are reported in table 1. For the extended description of the identification process, please refer to our preliminary work (Ottinger et al., 2015) 
LPV-BASED ROBUST GAIN-SCHEDULED CONTROLLER DESIGN
In this section a new LPV model is presented on the base of the nonlinear Bergman's minimal model, which is then used to design a robust discrete LPV-based gain-scheduled controller for T1DM.
LPV model of T1DM
The Bergman's model (1) with the insulin absorbation model (2) can be transfomed to the following LPV model with substitutions x 1 (t) = G(t), x 2 (t) = X(t), x 3 (t) = S 1 (t), x 4 (t) = S 2 (t), x 5 (t) = I(t) and u(t) = v(t)
where θ(t) ∈ Ω is a vector of scheduled parameters and
The coefficient a(θ) is used to cover the nonlinear part of (1b) X(t)G(t) → x 1 x 2 in the following way a(θ) = G(t) ⇒ a 0 + a 1 θ 1 = x 1 ⇒ a(θ)x 2 = x 1 x 2 (6) where θ 1 (t) = y−a0 a1 . The coefficients a 0 and a 1 were calculated so as to maintain the scheduling parameter θ 1 in the range −1, 1
Note, the coefficients a i , i = 2, 3, 4, 5 are equal to zero. Similarly, the coefficient b(θ) is calculated in the following way
8) where coefficients b 0 and b 2 are calculated so as to maintain the scheduling parameter θ 2 in the range −1, 1 (uncertainty) and b i = 0, i = 1, 4, 5 as well as θ 3 (t) ∈ −1, 1 is unknown but constant parameter describing uncertainty.
For parameters p 1 and p 3 we also considered an uncertainty (±5%) p 1 (θ) = p 10 + p 14 θ 4 , p 3 (θ) = p 30 + p 35 θ 5 (9) where p 10 = p 1 , p 14 = 5 % of p 1 , p 30 = p 3 , p 35 = 5 % of p 3 , p 1i = 0, i = 1, 2, 3, 5, p 3i = 0, i = 1, 2, 3, 4 and θ 4 , θ 5 ∈ −1, 1 are unknown but constant parameters.
For the robust discrete LPV-based gain-scheduling controller design the model (5) is transformed to discrete time-space and W (θ) is neglected, because has no effect on stability.
Robust gain-scheduled controller design
The output feedback gain-scheduled control law is considered for discrete-time PID (often denoted as PSD) controller in the form
where e(k) = y(k)−w(k) is control error, w(k) is reference value and gain matrices K P (·), K I (·), K D (·) are controller parameter matrices 1 (indexes P, I, D means proportional, sum (integral) and first difference (derivative), respectively) in the form
Note that the number of controller gain matrices is only 2 (for θ 1 and θ 2 ), the rest 3 (uncertainty) is equal to zero. Because the reference signal w(k) does not influence the closed-loop stability, we assume that it is equal to zero. For w(k) = 0, the control law (10) can be rewritten as
State space description of PID controllers can be derived in the following way (Veselý and Rosinová, 2013) . We can extend the system with two state variables
Control law (12) can be transformed to matrix form
T is the extended measurement output vector and
Substituting the control law (13) to the discrete uncertain LPV system the closed-loop system is obtained in the form
wherex ( To access the performance quality a quadratic cost function (Engwerda and Weeren, 2008) known from LQ theory is used in this paper, where weighting matrices depends on scheduling parameters (Ilka and Veselý, 2014b) . Using this approach we can affect performance quality in each operating point separately. The quadratic cost function is then in the form
where
n×n , R ∈ R m×m are symmetric positive definite (semidefinite) and definite matrices, respectively. The concept of guaranteed cost control is used in a standard way. Definition 1. Consider the system (5) with control algorithm (10). If there exists a control law u * and a positive scalar J * such that the closed-loop system (14) is stable and the value of closed-loop cost function (15) satisfies J ≤ J * then J * is said to be a guaranteed cost and u * guaranteed cost control law for system (5).
Substituting the control law (12) to the quadratic cost function (15) we can obtain
Definition 2. (Apkarian et al., 1995) The linear closedloop system (14) for θ ∈ Ω is quadratically stable if and only if there exist a symmetric positive definite matrix P > 0 and for the first difference of Lyapunov function V (k) = x T P x along the trajectory of closed-loop system (14) holds
From LQ theory we introduce the well known results. Lemma 1. (Kuncevič and Lyčak, 1977) Consider the closed-loop system (14). Closed-loop system (14) is affinely quadratically stable with guaranteed cost if and only if the following inequality holds
Proof 1. Proof is based on Lemma 1 and 2. From (18) we can obtain
Using Schur complement we obtain
After we extend (23) to affine form we obtain (19) and (20) which proofs the Theorem 1.
Note that Theorem 1 in its presented form is in the form of BMI. One can use a free and open source BMI solver PENLAB or we can linearize the nonlinear part of (19) to use LMI solver (LMILAB or SEDUMI ).
(24) where in each iteration pores X = P . Using this linearization, the element obtaining the nonlinear part (M 0 ) become as follows
SIMULATION EXPERIMENTS
In this section the proposed robust discrete gain-scheduled controller is verified using the individualized T1DM Bergman's model served as a patient. For controller synthesis the LPV model described in section 3.1 with parameters presented in section 2.2, transformed to discrete time-space with sample time T s = 5 min was used. The response of Bergman's model with the discrete LPV model to an insulin bolus is shown in Fig 1. The disturbance has been considered in the form of mixed meal ingestion. The main objective was to keep the blood glucose concentration levels within normal glycemic range (3.8 -10 mmol/l). The obtained model was extended for robust discrete gainscheduled PID controller design (14). Then using Theorem 1 with weighting matrices Q = q i I, q 0 = 1 × 10 −5 , q 1 = 1 × 10 −1 , q 2 = 1 × 10 −2 , q 3 = q 4 = q 5 = 0 R = rI, r = 1 and ξ L ≤ P (θ) ≤ ξ U , ξ U = 1 × 10 8 , ξ L = 1 × 10 −5 , T s = 5 min with LMILAB one can obtain robust discrete gain-scheduled controller in the form (10) where Fig. 2 . During manual administration of insulin by the T1DM subject, the measured glycemia has been higher than 10 mmol/l during 45% of the monitored time. In the case of automatic dosing controlled by the proposed gain-scheduled algorithm, the time when glycemia reached the level of 10 mmol/l or more was reduced to 9.9% of the simulation time.
CONCLUSION
The paper addresses the problem of the robust discrete gain-scheduled controller design for Bergman's minimal model of glucose-insulin dynamics coupled with insulin absorption subsystem and carbohydrates absorption subsystem. The obtained design procedure can be implemented easily to the standard LMI or BMI approaches. It can be used in low-cost micro-controllers, which is specifically beneficial for systems where we need to save the operation energy. The presented theory opens new possibilities for further research and study in this area.
